ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
68.056,94
0,49%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Calliditas Therapeutics AB (PK) (CLTEF)

  7. Calliditas Therapeutics AB (PK) (CLTEF) News

CLTEF

Calliditas Therapeutics AB (PK) (CLTEF)

Calliditas Therapeutics AB (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:CLTEF
DatumZeitQuelleÜberschriftSymbolFirma
06/05/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
25/04/202422h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
06/03/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
21/02/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
11/12/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
30/11/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
24/11/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
07/11/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
05/10/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
27/09/202322h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
18/08/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
17/08/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
17/07/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:CLTEFCalliditas Therapeutics AB (PK)
12/06/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:CLTEFCalliditas Therapeutics AB (PK)
08/06/202322h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
30/05/202322h22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
16/05/202322h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
13/03/202321h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
13/03/202311h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
23/02/202322h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
02/02/202322h08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
01/02/202322h58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CLTEFCalliditas Therapeutics AB (PK)
31/01/202322h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
30/12/202222h30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
13/12/202222h31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
15/11/202222h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
21/10/202222h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
20/09/202222h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
29/07/202222h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
15/07/202222h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:CLTEFCalliditas Therapeutics AB (PK)
 Showing the most relevant articles for your search:USOTC:CLTEF

Kürzlich von Ihnen besucht

NYSE
XOM
Exxon Mobil
TG
NOV
Novo Nordisk
DBI
DAX
DAX
DBI
SDXP
SDAX
USOTC
ADDYY
Adidas (QX)
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
TG
MBG
MercedesBenz
TG
ALV
Allianz
TG
BAYN
Bayer
TG
DTE
Deutsche Telekom
NASDAQ
NVDA
NVIDIA
CCOM
US100
US Tech 100
USOTC
BASFY
BASF (QX)
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten